Synthesis and biological evaluation of a tumor-selective degrader of PARP1

C Pu, S Wang, D Luo, Y Liu, X Ma, H Zhang… - Bioorganic & Medicinal …, 2022 - Elsevier
Abstract Poly (ADP-ribose) polymerase (PARP) inhibitors show potent antiproliferative
activity in treatment with triple-negative breast cancer (TNBC) when combined with …
被引用次数：9 相关文章

Synthesis and biological evaluation of a tumor-selective degrader of PARP1

C Pu, S Wang, D Luo, Y Liu, X Ma… - Bioorganic & …, 2022 - pubmed.ncbi.nlm.nih.gov
Poly (ADP-ribose) polymerase (PARP) inhibitors show potent antiproliferative activity in
treatment with triple-negative breast cancer (TNBC) when combined with chemotherapeutic …

Synthesis and biological evaluation of a tumor-selective degrader of PARP1.

C Pu, S Wang, D Luo, Y Liu, X Ma, H Zhang… - Bioorganic & …, 2022 - europepmc.org
Poly (ADP-ribose) polymerase (PARP) inhibitors show potent antiproliferative activity in
treatment with triple-negative breast cancer (TNBC) when combined with chemotherapeutic …